Zimmer Biomet Holdings, Inc. (ZBH) — Financial statements
Income statement, balance sheet, and cash flow for Zimmer Biomet Holdings, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 8,232↑7.2% | 7,679↑3.8% | 7,394↑6.5% | 6,940↑1.6% | 6,827 | |
| Cost of Revenue | 3,160↑44.2% | 2,191↑5.2% | 2,084↑3.2% | 2,020↑3.0% | 1,960 | |
| Gross Profit | 5,072↓7.6% | 5,487↑3.3% | 5,310↑7.9% | 4,920↑1.1% | 4,867 | |
| Operating Expenses | ||||||
| R&D Expenses | 459↑4.8% | 437↓4.6% | 459↑13.0% | 406↓6.8% | 436 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 3,251↑11.0% | 2,930↑3.2% | 2,839↑2.8% | 2,762↓2.9% | 2,843 | |
| Other Expenses | 0.00↓100.0% | 835↑13.5% | 735↓30.4% | 1,056↑45.2% | 727 | |
| Operating Expenses | 3,710↓11.7% | 4,202↑4.2% | 4,033↓4.5% | 4,224↑5.4% | 4,007 | |
| Total Costs & Expenses | 6,869↑7.5% | 6,393↑4.5% | 6,117↓2.0% | 6,244↑4.6% | 5,967 | |
| Operating Results | ||||||
| Operating Income | 1,362↑6.0% | 1,286↑0.6% | 1,278↑83.5% | 696↓19.1% | 860 | |
| Depreciation & Amortization | 1,094↑9.8% | 996↑4.7% | 952↑2.7% | 926↓1.2% | 938 | |
| EBITDA | 2,217↓1.5% | 2,251↑1.4% | 2,220↑48.5% | 1,495↓9.1% | 1,645 | |
| EBIT | 1,124↓10.4% | 1,255↓1.1% | 1,269↑123.2% | 568↓19.7% | 707 | |
| Interest & Other Income | ||||||
| Net Interest Income | -293↓34.3% | -218↓8.3% | -201↓22.1% | -165↑20.9% | -208 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 293↑34.3% | 218↑8.3% | 201↑22.1% | 165↓20.9% | 208 | |
| Non-Operating Income | 239↑667.2% | 31↑238.0% | 9↓92.8% | 128↓16.3% | 153 | |
| Other Income / Expenses | -531↓113.3% | -249↓18.4% | -210↑28.1% | -293↑19.0% | -361 | |
| Income Before Tax | 831↓19.9% | 1,037↓2.9% | 1,067↑164.5% | 404↓19.1% | 499 | |
| Income Tax Expense | 126↓4.3% | 131↑211.4% | 42↓62.4% | 112↑109.9% | 54 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 705↓22.1% | 905↓11.7% | 1,025↑252.0% | 291↓34.6% | 446 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00↑100.0% | -59↓35.5% | -43 | |
| Net Income | 705↓22.0% | 904↓11.7% | 1,024↑342.5% | 231↓42.4% | 402 | |
| Bottom-Line Net Income | 705↓22.0% | 904↓11.7% | 1,024↑342.5% | 231↓42.4% | 402 | |
| EPS (Basic) | 3.56↓20.0% | 4.45↓9.4% | 4.91↑346.4% | 1.10↓43.0% | 1.93 | |
| EPS (Diluted) | 3.55↓19.9% | 4.43↓9.2% | 4.88↑343.6% | 1.10↓42.4% | 1.91 | |
| Weighted Average Shares | 198↓2.5% | 203↓2.7% | 209↓0.4% | 210↑0.5% | 209 | |
| Weighted Average Diluted Shares | 199↓2.6% | 204↓2.8% | 210↓0.3% | 210↓0.0% | 210 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.